World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
124
Citations
107512
World Ranking
3144
National Ranking
1738

Overview

Roger Stupp is affiliated with Northwestern University in the United States and has produced a substantial body of research primarily in the field of medicine. Their work extensively covers subfields such as genetics, oncology, biomedical engineering, pulmonary and respiratory medicine, and molecular biology.

The scientist's research focuses on several key topics, including:

  • Glioma Diagnosis and Treatment
  • Ultrasound and Hyperthermia Applications
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Research and Treatments
  • Brain Metastases and Treatment
  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research

Notable recent papers authored or coauthored by Roger Stupp include:

  • cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas (2020), published in Acta Neuropathologica
  • RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults (2023), published in Journal of Clinical Oncology
  • Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial (2023), published in Nature Medicine
  • Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment (2023), published in Journal of Clinical Investigation
  • Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial (2021), published in The Lancet Oncology

Frequent coauthors collaborating with Roger Stupp include:

  • Adam M. Sonabend
  • Craig Horbinski
  • Víctor A. Arrieta
  • Michael Weller
  • Andrew Gould

The scientist's work has been published repeatedly in several key venues. These include:

  • Neuro-Oncology
  • Neuro-Oncology Advances
  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • Neurosurgery

Best Publications

  • Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

    Roger Stupp;Warren P. Mason;Martin J. van den Bent;Michael Weller

  • Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

    Roger Stupp;Monika E. Hegi;Warren P. Mason;Martin J. van den Bent

  • MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma

    Monika E Hegi;Annie-Claire Diserens;Thierry Gorlia;Marie-France Hamou

  • Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

    Patrick Y. Wen;David R. Macdonald;David A. Reardon;Timothy F. Cloughesy

  • Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial

    Roger Stupp;Roger Stupp;Roger Stupp;Sophie Taillibert;Sophie Taillibert;Andrew Kanner;William Read;William Read

  • Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial

    Annika Malmström;Bjørn Henning Grønberg;Christine Marosi;Roger Stupp

  • Maintenance therapy with tumor-Treating fields plus temozolomide vs temozolomide alone for glioblastoma a randomized clinical trial

    Roger Stupp;Roger Stupp;Sophie Taillibert;Andrew A. Kanner;Santosh Kesari

  • Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

    Roger Stupp;Roger Stupp;Monika E Hegi;Thierry Gorlia;Sara C Erridge

  • Promising Survival for Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Concomitant Radiation Plus Temozolomide Followed by Adjuvant Temozolomide

    Roger Stupp;Pierre Yves Dietrich;Sandrine Ostermann Kraljevic;Alessia Pica

  • Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

    Mark R. Gilbert;Meihua Wang;Kenneth D. Aldape;Roger Stupp

  • Clinical Trial Substantiates the Predictive Value of O-6-Methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastoma Patients Treated with Temozolomide

    Monika E. Hegi;Annie Claire Diserens;Sophie Godard;Pierre Yves Dietrich

  • Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity

    Monika E. Hegi;Lili Liu;James G. Herman;Roger Stupp

  • Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma

    Roger Stupp;Roger Stupp;Roger Stupp;Sophie Taillibert;Sophie Taillibert;Andrew Kanner;William Read;William Read

  • European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas

    Michael Weller;Martin van den Bent;Jörg C Tonn;Roger Stupp

  • NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality

    Roger Stupp;Eric T. Wong;Andrew A. Kanner;David Steinberg

  • Lomustine and Bevacizumab in Progressive Glioblastoma

    Wolfgang Wick;Thierry Gorlia;Martin Bendszus;Martin Taphoorn

  • Stem Cell–Related “Self-Renewal” Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in Glioblastoma

    Anastasia Murat;Eugenia Migliavacca;Thierry Gorlia;Wanyu L Lambiv

  • MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

    Michael Weller;Roger Stupp;Guido Reifenberger;Alba A. Brandes

  • cIMPACT-NOW Update 3: Recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”

    Daniel J. Brat;Kenneth Aldape;Howard Colman;Eric C. Holland

  • High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    R. Stupp;M. Brada;M. J. van den Bent;J.-C. Tonn

Frequent Co-Authors

Monika E. Hegi
Monika E. Hegi University of Lausanne
Michael Weller
Michael Weller University of Zurich
Wolfgang Wick
Wolfgang Wick German Cancer Research Center
Martin J. van den Bent
Martin J. van den Bent Erasmus University Rotterdam
Alba A. Brandes
Alba A. Brandes Institute of Neurological Sciences
David A. Reardon
David A. Reardon Harvard University
Mauro Delorenzi
Mauro Delorenzi University of Lausanne
Rolf A. Stahel
Rolf A. Stahel University of Zurich
Mark R. Gilbert
Mark R. Gilbert National Institutes of Health
Craig Horbinski
Craig Horbinski Northwestern University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine but seeking flexible study or alternative career routes, there are a range of online degrees and certifications to consider. Many health care roles now offer quality online programs, making it easier to start or advance your career from anywhere in the world.

If you are drawn to administrative roles, completing medical billing and coding classes online can prepare you for vital support positions in hospitals and clinics. These programs teach you essential skills for handling medical records, insurance claims, and healthcare data.

For those who wish to become advanced practice nurses, exploring affordable online fnp programs can be a practical option. Family Nurse Practitioner programs online are designed for working nurses who want to take on broader responsibilities.

Students interested in starting a nursing career can consider online nursing courses. These courses often offer flexible schedules and pathways to licensure, ideal for busy adults.

If you're aiming for leadership and research roles, the cheapest phd nursing programs online allow experienced nurses to earn terminal degrees and contribute to healthcare innovation while managing existing work or family commitments.

Best Scientists Citing Roger Stupp

Trending Scientists

Recently Published Articles